Low Fat Milk Intake and Cardio Vascular Risk (CVR) Indicators in Children
NCT ID: NCT01178515
Last Updated: 2011-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
650 participants
INTERVENTIONAL
2010-09-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
NCT07087184
Impact of Low-fat and Full-fat Milk on Lipids and Cardiac Function in Patients With Coronary Artery Disease
NCT06542172
Study of the Impact of Trans Fatty Acids From Dairy Products on Cardiovascular Risk Factors
NCT01163175
Trans Fatty Acids and Cardiovascular Risk Factors
NCT00439582
Milk as a Recovery Beverage After Exercise for Improving Metabolic Health
NCT03154216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Full fat milk
Full fat milk contain 3% fat
Modification of the content of fat in milk
Comparison of three levels of fat content in cow´s milk
Partially defatted milk
Partially defatted milk contains 2% of fat
Modification of the content of cows milk
Comparison of three levels of fat content in cows' milk
Defatted milk
Defatted milk contains 1% fat
Modification of the fat content of cows´ milk
Comparison of three levels of fat content in cow´milk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modification of the content of fat in milk
Comparison of three levels of fat content in cow´s milk
Modification of the content of cows milk
Comparison of three levels of fat content in cows' milk
Modification of the fat content of cows´ milk
Comparison of three levels of fat content in cow´milk
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Nacional de Salud Publica, Mexico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Instituto Nacional de Salud Publica
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salvador Villalpando, MD, Ph D
Role: PRINCIPAL_INVESTIGATOR
Instituto Nacional de Salud Publica, Mexico
Teresa Shamah, M. Sc.
Role: STUDY_CHAIR
Instituto Nacional de Salud Publica, Mexico
Yaveth Lara, M Sc
Role: STUDY_CHAIR
Instituto Nacional de Salud Publica, Mexico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comisíon para el Desarrollo de Pueblos Indigenas
Pachuca, Hidalgo, Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, Hill K, Ezzati M. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008 Jun 17;5(6):e125. doi: 10.1371/journal.pmed.0050125.
Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998 Jun 4;338(23):1650-6. doi: 10.1056/NEJM199806043382302.
Freedman DS. Clustering of coronary heart disease risk factors among obese children. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1099-108. doi: 10.1515/JPEM.2002.15.8.1099.
Aguilar-Salinas CA, Gomez-Perez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52 Suppl 1:S44-53. doi: 10.1590/s0036-36342010000700008.
Corvalan C, Uauy R, Kain J, Martorell R. Obesity indicators and cardiometabolic status in 4-y-old children. Am J Clin Nutr. 2010 Jan;91(1):166-74. doi: 10.3945/ajcn.2009.27547. Epub 2009 Nov 18.
Villalpando S, Carrión C, Barquera S, Olaiz G, Robledo R. The body mass index is associated with hyperglycemia and alterations of some components of the metabolic syndrome in Mexican adolescents aged 10-19 years. Salud Pub Mex 2007; 49:s324-s330.
Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol. 1991 May 1;133(9):884-99. doi: 10.1093/oxfordjournals.aje.a115968.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-865-6540
Identifier Type: OTHER
Identifier Source: secondary_id
Milk, Cardiovas risk, children
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.